Prognos Health
Prognos Health is a private healthcare data and analytics company that harmonizes clinical and genomic lab data, medical claims, and prescription claims across 325 million de-identified patients for U.S. pharmaceutical and life sciences customers, sold via enterprise field sales and a self-service data marketplace.
- Company typePrivate
- Founded2011
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Prognos Health does
Prognos Health is a private healthcare data and analytics company founded in 2011 and headquartered in New York City. The company operates a platform, branded Prognos Factor®, that ingests and harmonizes clinical and genomic laboratory data, medical claims, and prescription claims across 325 million de-identified patients sourced from 20+ data partners — positioning it as the largest dedicated provider of harmonized lab data for the U.S. life sciences market. Its core technical asset is Factor Logic™, a patent-pending query engine designed for instantaneous analysis of patient-centric healthcare records, paired with Clinical Truths™, an AI/ML and NLP layer that extracts clinical insight from pathology notes and structured lab results.
The company sells primarily to pharmaceutical and life sciences organizations through two motions: enterprise field sales targeting brand teams and a self-service Prognos Marketplace where customers can curate patient populations and purchase real-world data directly. Product modules span cohort design, patient journey analytics, brand-eligible patient alerts (integrated with Veeva CRM), physician segmentation, omnichannel marketing, outcomes research, and commercial analytics. Strategic partnerships with Datavant (tokenization across 400+ data providers) and Veeva (pharma CRM) embed Prognos into the operational fabric of pharma commercial workflows, while a programmatic activation partnership with Proclivity Systems extends its data into digital media execution.
Prognos has raised approximately $66.5 million in cumulative funding, including a $23.3 million round in May 2023 led by Marshall Wace and Safeguard Scientifics with participation from Cigna, Merck, Hikma Ventures, LabCorp, and Hunt Companies. The company employs 51-100 people and serves customers ranging from top-5 global pharmaceutical companies to small and midsize pharma, with a secondary payer segment. Pricing is quote-based on multi-year contracts and the company is U.S.-only, explicitly excluding international users per its terms of use.
Prognos Health firmographics
Firmographics- Name
- Prognos Health
- Legal name
- Prognos Health Inc.
- Website
- https://prognoshealth.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Prognos Health is a private healthcare data and analytics company that harmonizes clinical and genomic lab data, medical claims, and prescription claims across 325 million de-identified patients for U.S. pharmaceutical and life sciences customers, sold via enterprise field sales and a self-service data marketplace.
- Ownership category
- akta.pro rank
Prognos Health industry classification
Industry- Product category
- Healthcare Data Analytics
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Patient Stratification, Risk Prediction & Prognostic Modeling (HLAAANAH)
- akta.pro secondary industries
- Risk Stratification, Early Warning Scores & Predictive Analytics (HLACAGAE), Proteomics & Biomarker Analytical Testing (HLAGADAG)
Keywords
Where Prognos Health is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Prognos Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Healthcare Data Marketplace: Prognos operates a healthcare data marketplace where life sciences companies purchase real-world patient data including lab test results, medical claims, and prescription claims. Customers can curate patient populations and purchase underlying transaction-level data records through a single contract. The marketplace offers a la carte data purchases, eliminating overbuying or data overlap.
- Platform Software (Prognos Factor): Prognos Factor provides HCP data and analytics software as a platform solution. The platform enables queries of patient data, cohort design, patient journey analysis, omnichannel marketing, and physician segmentation. Revenue likely generated through platform subscription or licensing.
- Prognos Alerts: Near real-time alerts service that notifies pharmaceutical companies about physicians with brand-eligible patients. Alerts can be delivered weekly or on custom cadences and integrate with Veeva CRM systems.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Quote-based enterprise pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Prognos Health product offering
Product offeringCore offering
Prognos Health sells a healthcare data and analytics platform (Prognos Factor®) that delivers harmonized clinical and genomic laboratory data, medical claims, and prescription claims on 325M+ de-identified patients to life sciences companies. Customers use the platform and its Prognos Marketplace to design patient cohorts, analyze patient journeys, receive brand-eligible patient alerts, segment physicians, run outcomes research, and execute omnichannel HCP marketing.
Product overview
Prognos Health offers a unified healthcare data and analytics platform called Prognos Factor® that combines a core data platform with modular analytics products. The platform provides harmonized clinical and genomic laboratory data, medical claims, and prescription claims data across 325M+ de-identified patients. The ecosystem includes Prognos Marketplace for data purchasing, Cohort Designer for patient cohort building, Patient Journey for longitudinal analysis, Alerts for real-time brand-eligible patient notifications, Omnichannel Marketing for HCP outreach, Physician Segmentation for targeting, Outcomes for HEOR studies, and Commercial Analytics for brand strategy. All modules integrate with Datavant for data linkability and support Veeva CRM integration for sales workflow optimization.
Differentiator
Problem solved
Functional benefit
Brands
- Prognos Factor: HCP data and analytics software platform providing purpose-built healthcare data assets for answering complex healthcare questions.
- Prognos Marketplace
- Prognos Oncology
- Prognos Rare Disease
- Prognos Clinical Truths
Products and services
- Prognos Factor® Core healthcare data and analytics platform providing access to harmonized clinical and genomic laboratory data on 325M+ de-identified patients, medical claims, prescription claims, and HCP data for life sciences companies. Features patent-pending Factor Logic™ query engine and Clinical Truths™ AI/ML.
- Prognos Marketplace Self-service healthcare data marketplace enabling life sciences companies to explore, curate, and purchase real-world patient data with a la carte pricing, eliminating overbuying and data overlap. Uses Datavant tokenization for downstream linkability with 400+ ecosystem data providers.
Quantifiable outcome
- Time to insight reduced from months to 30 days
- +3 more outcomes
Companies that use Prognos Health
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles3 records
Prognos Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature4 records
Prognos Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and secondary.
- DatavantcoreDatavant provides tokenization technology that standardizes patient-level data across the Prognos Marketplace. This partnership enables data interoperability with Datavant's ecosystem of over 400 data providers, allowing customers to easily integrate Prognos data with other tokenized datasets without contracting anew.
- Veeva SystemscorePrognos Alerts integrate directly with Veeva Suggestions, enabling pharmaceutical sales reps to receive brand-eligible patient leads within their existing Veeva CRM workflow. This integration closes the loop faster between data insights and field sales activity.
- Proclivity SystemssecondaryProclivity Systems is a programmatic advertising platform partner that Prognos works with to activate data-driven insights for digital marketing campaigns. The partnership enables seamless integration of Prognos patient insights into programmatic advertising execution.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Prognos Health competitors and assessment
Company assessmentDirect peers
- Komodo Health: Patient-level healthcare data and analytics platform serving life sciences with cohort, journey, and HCP targeting use cases — the most direct functional analog to Prognos Factor.
- Aetion: Real-world evidence analytics platform used by pharma for regulatory-grade evidence generation and commercial analytics, overlapping heavily with Prognos's RWD outcomes offering.
- Symphony Health (an ICON company): Provides integrated US claims, prescription, and clinical data to pharma for commercial and HEOR analytics — directly competes in patient cohorting and HCP targeting.
- Flatiron Health: Oncology-focused real-world data and EHR analytics for life sciences, now part of Roche; competes with Prognos Oncology across cohort design, patient journey, and evidence generation.
- COTA Healthcare: Oncology real-world data company serving pharma with curated EHR and claims-derived datasets; directly comparable to Prognos Oncology for cohort, journey, and evidence use cases.
Broad incumbents
- IQVIA: Largest life sciences R&D and commercial data franchise globally, offering claims, EHR, and oncology datasets that compete with Prognos in pharma commercial analytics at much broader scale.
- Optum (UnitedHealth Group): Operates one of the largest US claims, EHR, and pharmacy data assets under UnitedHealth; competes broadly in life sciences RWD and is also a Datavant-aligned ecosystem participant.
- ConvergeHEALTH by Deloitte: Deloitte's life sciences RWE and real-world data analytics business, combining consulting with data assets for pharma outcomes and commercial analytics — adjacent incumbent to Prognos.
Emerging players
- Truveta: Health-system consortium aggregating de-identified EHR, claims, and genomics data for life sciences — an emerging RWD competitor with broader data scope but less lab specialization.
Others
- Datavant: Healthcare data connectivity and tokenization partner that Prognos relies on for Marketplace interoperability across 400+ data providers — ecosystem participant rather than direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Prognos Health social profiles
Digital presencePrognos Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prognos Health leadership team
Management profileNumber of profiles
Profiles10 records
Prognos Health funding detail
Funding detailFunding overview
Funding rounds5 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prognos Health M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prognos Health
What does Prognos Health do?
Prognos Health sells a healthcare data and analytics platform (Prognos Factor®) that delivers harmonized clinical and genomic laboratory data, medical claims, and prescription claims on 325M+ de-identified patients to life sciences companies. Customers use the platform and its Prognos Marketplace to design patient cohorts, analyze patient journeys, receive brand-eligible patient alerts, segment physicians, run outcomes research, and execute omnichannel HCP marketing.
Is Prognos Health a public or private company?
Prognos Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Prognos Health founded?
Prognos Health was founded in 2011. It employs 51 to 100 people.
Where is Prognos Health based?
Prognos Health is headquartered in New York, United States, in the North America region.
How does Prognos Health make money?
Three revenue lines are on record. Healthcare Data Marketplace is the primary driver. The others are platform Software (Prognos Factor) and prognos Alerts.
Who are Prognos Health's main competitors?
Direct peers on record are Komodo Health, Aetion, Symphony Health (an ICON company), Flatiron Health and COTA Healthcare. Broad incumbents are IQVIA, Optum (UnitedHealth Group) and ConvergeHEALTH by Deloitte. Truveta is listed as an emerging player. Datavant is listed as an others.
Does Prognos Health have an API?
No public API is recorded for Prognos Health.
What industry is Prognos Health in?
Prognos Health's product category is Healthcare Data Analytics. Its primary akta.pro industry code is HLAAANAH, Patient Stratification, Risk Prediction & Prognostic Modeling, with a secondary code of HLACAGAE, Risk Stratification, Early Warning Scores & Predictive Analytics. Its SIC code is 7372.